Incidence of thromboembolic events in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy
暂无分享,去创建一个
I. Verdinelli | V. Tombolini | F. Morano | D. Musio | S. Mezi | E. Orsi | F. De Felice | N. Raffetto | Errico Orsi
[1] T. Hothorn,et al. O-0028PREOPERATIVE CHEMORADIOTHERAPY AND POSTOPERATIVE CHEMOTHERAPY WITH 5-FLUOROURACIL AND OXALIPLATIN VERSUS 5-FLUOROURACIL ALONE IN LOCALLY ADVANCED RECTAL CANCER: RESULTS OF THE GERMAN CAO/ARO/AIO-04 RANDOMIZED PHASE III TRIAL , 2014 .
[2] L. Boni,et al. Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] T. Hothorn,et al. Preoperative chemoradiotherapy and postoperative chemotherapy with 5-fluorouracil and oxaliplatin versus 5-fluorouracil alone in locally advanced rectal cancer: First results of the German CAO/ARO/AIO-04 randomized phase III trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] N. Petrelli,et al. The impact of capecitabine and oxaliplatin in the preoperative multimodality treatment in patients with carcinoma of the rectum: NSABP R-04. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] H. Abdel-Razeq,et al. Incidental pulmonary embolism in cancer patients: clinical characteristics and outcome – a comprehensive cancer center experience , 2011, Vascular health and risk management.
[6] T. Hothorn,et al. Preoperative chemoradiotherapy and postoperative chemotherapy with 5-fluorouracil and oxaliplatin versus 5-fluorouracil alone in locally advanced rectal cancer: First results of the German CAO/ARO/AIO-04 randomized phase III trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] A. Khorana,et al. Emerging risk stratification approaches to cancer-associated thrombosis: risk factors, biomarkers and a risk score. , 2010, Thrombosis research.
[8] Christophe Hennequin,et al. Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] A. Norman,et al. Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum, and fluoropyrimidine combination chemotherapy: a report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Group. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] Gary H Lyman,et al. Development and validation of a predictive model for chemotherapy-associated thrombosis. , 2008, Blood.
[11] Lars Påhlman,et al. Late adverse effects of radiation therapy for rectal cancer – a systematic overview , 2007, Acta oncologica.
[12] Daniel Azoulay,et al. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] H. Chew,et al. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] A. Norman,et al. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] Tufia C Haddad,et al. Chemotherapy-induced thrombosis. , 2006, Thrombosis research.
[16] J. Heit. Cancer and venous thromboembolism: scope of the problem. , 2005, Cancer control : journal of the Moffitt Cancer Center.